CTC Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,300
Closed -$1.39M 141
2022
Q2
$1.39M Buy
+4,300
New +$1.29M 1.51% 8

Other funds holding LLY

CTC Capital Management's LLY Position: Q3 2022 in Review

CTC Capital Management sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 4,300 shares — an estimated $1.39M sold.

CTC Capital Management first reported a position in LLY in Q2 2022 and held it in 1 quarter. The position peaked at $1.39M in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • CTC Capital Management reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • CTC Capital Management sold 4,300 Eli Lilly shares in Q3 2022, an estimated $1.39M.
  • CTC Capital Management first reported a position in Eli Lilly in Q2 2022 and held it in 1 quarter.
  • CTC Capital Management's Eli Lilly position peaked at $1.39M in Q2 2022.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on CTC Capital Management's 13F filing for Q3 2022, filed 20 Oct 2022.